These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

78 related items for PubMed ID: 25910294

  • 1. Serum peptidome patterns of hepatocellular carcinoma based on magnetic bead separation and mass spectrometry analysis.
    Li K, He WH, Fan NJ, Gao CF, Zhao G, Sun GB, Zheng GB.
    Turk J Gastroenterol; 2014 Dec; 25 Suppl 1():147-52. PubMed ID: 25910294
    [Abstract] [Full Text] [Related]

  • 2. Serum peptidome patterns for early screening of esophageal squamous cell carcinoma.
    Fan NJ, Gao CF, Zhao G, Wang XL, Qiao L.
    Biotechnol Appl Biochem; 2012 Dec; 59(4):276-82. PubMed ID: 23586861
    [Abstract] [Full Text] [Related]

  • 3. Serum peptide pattern that differentially diagnoses hepatitis B virus-related hepatocellular carcinoma from liver cirrhosis.
    Wang N, Cao Y, Song W, He K, Li T, Wang J, Xu B, Si HY, Hu CJ, Li AL.
    J Gastroenterol Hepatol; 2014 Dec; 29(7):1544-50. PubMed ID: 24612022
    [Abstract] [Full Text] [Related]

  • 4. Serum peptidome patterns of colorectal cancer based on magnetic bead separation and MALDI-TOF mass spectrometry analysis.
    Fan NJ, Gao CF, Wang XL, Zhao G, Liu QY, Zhang YY, Cheng BG.
    J Biomed Biotechnol; 2012 Dec; 2012():985020. PubMed ID: 23091368
    [Abstract] [Full Text] [Related]

  • 5. Serum peptidome patterns of breast cancer based on magnetic bead separation and mass spectrometry analysis.
    Fan NJ, Gao CF, Zhao G, Wang XL, Liu QY.
    Diagn Pathol; 2012 Apr 20; 7():45. PubMed ID: 22521044
    [Abstract] [Full Text] [Related]

  • 6. Serum peptidome patterns of hepatocellular carcinoma based on magnetic bead separation and mass spectrometry analysis.
    Ying X, Han SX, Wang JL, Zhou X, Jin GH, Jin L, Wang H, Wu L, Zhang J, Zhu Q.
    Diagn Pathol; 2013 Aug 05; 8():130. PubMed ID: 23915185
    [Abstract] [Full Text] [Related]

  • 7. Comparative serum proteomic analysis of serum diagnosis proteins of colorectal cancer based on magnetic bead separation and maldi-tof mass spectrometry.
    Deng BG, Yao JH, Liu QY, Feng XJ, Liu D, Zhao L, Tu B, Yang F.
    Asian Pac J Cancer Prev; 2013 Aug 05; 14(10):6069-75. PubMed ID: 24289627
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Application of surface-enhanced laser desorption/ionization time-of-flight mass spectrometry coupled with an artificial neural network model for the diagnosis of hepatocellular carcinoma.
    Hu Q, Huang Y, Wang Z, Tao H, Liu J, Yan L, Wang K.
    Hepatogastroenterology; 2012 Sep 05; 59(118):1902-6. PubMed ID: 22193438
    [Abstract] [Full Text] [Related]

  • 10. Serum profiling based on fucosylated glycoproteins for differentiating between chronic hepatitis B and hepatocellular carcinoma.
    Liao J, Zhang R, Qian H, Cao L, Zhang Y, Xu W, Li J, Wu M, Yin Z.
    Biochem Biophys Res Commun; 2012 Apr 06; 420(2):308-14. PubMed ID: 22425980
    [Abstract] [Full Text] [Related]

  • 11. Serum DKK1 as a protein biomarker for the diagnosis of hepatocellular carcinoma: a large-scale, multicentre study.
    Shen Q, Fan J, Yang XR, Tan Y, Zhao W, Xu Y, Wang N, Niu Y, Wu Z, Zhou J, Qiu SJ, Shi YH, Yu B, Tang N, Chu W, Wang M, Wu J, Zhang Z, Yang S, Gu J, Wang H, Qin W.
    Lancet Oncol; 2012 Aug 06; 13(8):817-26. PubMed ID: 22738799
    [Abstract] [Full Text] [Related]

  • 12. Surface enhanced laser desorption/ionization profiling: New diagnostic method of HBV-related hepatocellular carcinoma.
    Wu C, Wang Z, Liu L, Zhao P, Wang W, Yao D, Shi B, Lu J, Liao P, Yang Y, Zhu L.
    J Gastroenterol Hepatol; 2009 Jan 06; 24(1):55-62. PubMed ID: 18823443
    [Abstract] [Full Text] [Related]

  • 13. Toward the proteomic identification of biomarkers for the prediction of HBV related hepatocellular carcinoma.
    He QY, Zhu R, Lei T, Ng MY, Luk JM, Sham P, Lau GK, Chiu JF.
    J Cell Biochem; 2008 Feb 15; 103(3):740-52. PubMed ID: 17557278
    [Abstract] [Full Text] [Related]

  • 14. Mass spectrometry-based serum peptide profiling in hepatocellular carcinoma with bone metastasis.
    He J, Zeng ZC, Xiang ZL, Yang P.
    World J Gastroenterol; 2014 Mar 21; 20(11):3025-32. PubMed ID: 24659894
    [Abstract] [Full Text] [Related]

  • 15. Metabolomics study of hepatocellular carcinoma: discovery and validation of serum potential biomarkers by using capillary electrophoresis-mass spectrometry.
    Zeng J, Yin P, Tan Y, Dong L, Hu C, Huang Q, Lu X, Wang H, Xu G.
    J Proteome Res; 2014 Jul 03; 13(7):3420-31. PubMed ID: 24853826
    [Abstract] [Full Text] [Related]

  • 16. Early diagnostic potential for hepatocellular carcinoma using the SELDI ProteinChip system.
    Kanmura S, Uto H, Kusumoto K, Ishida Y, Hasuike S, Nagata K, Hayashi K, Ido A, Stuver SO, Tsubouchi H.
    Hepatology; 2007 Apr 03; 45(4):948-56. PubMed ID: 17393466
    [Abstract] [Full Text] [Related]

  • 17. SELDI-TOF MS proteinchip technology for screening of serum markers of HBV-induced hepatocellular carcinoma.
    Geng X, Wang F, Li YG, Zhu GP, Zhang WM.
    J Exp Clin Cancer Res; 2007 Dec 03; 26(4):505-8. PubMed ID: 18365545
    [Abstract] [Full Text] [Related]

  • 18. Serum peptidome profiling for identifying pathological patterns in patients with primary nephrotic syndrome.
    Huang LT, Wen Q, Zhao MZ, Li ZB, Luo N, Wang YT, Dong XQ, Yu XQ.
    Chin Med J (Engl); 2012 Dec 03; 125(24):4418-23. PubMed ID: 23253712
    [Abstract] [Full Text] [Related]

  • 19. Proteomic profiling of hepatitis B virus-related hepatocellular carcinoma with magnetic bead-based matrix-assisted laser desorption/ionization time-of-flight mass spectrometry.
    Liu T, Xue R, Huang X, Zhang D, Dong L, Wu H, Shen X.
    Acta Biochim Biophys Sin (Shanghai); 2011 Jul 03; 43(7):542-50. PubMed ID: 21659380
    [Abstract] [Full Text] [Related]

  • 20. MALDI-TOF MS combined with magnetic beads for detecting serum protein biomarkers and establishment of boosting decision tree model for diagnosis of hepatocellular carcinoma.
    Liu C, Shen J, Pan C, Yang L, Mou S, Wang H, Liang Y.
    Am J Clin Pathol; 2010 Aug 03; 134(2):235-41. PubMed ID: 20660326
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 4.